uCrest Makes Investment in US-Based Vital Signs Medical Firm

UCrest Berhad has signed agreement to invest and to lead the investment of Docsun Biomed Limited.

Docsun Biomed Limited is a holding company that owns a leading US medical technology company that has developed non-contact, non-invasive, non-intrusive vital signs and it has a subsidiary in Taiwan and India. Docsun Non-Contact Vitals technologies have already been used in hospitals as Health Monitoring System (HMS) and integrated into dashboard in monitoring the health status of drivers of public transportation and trucks.

In addition, both parties also agreed to cross-licensing each other’s technologies that Docsun non-contact vital technology to be integrated with iMedic as integrated product, “iMedic with non-contact vitals” to market globally.

The integrated product is the first digital health platform in the world that consists of Smart Clinic Management System (CMS) with robust digitalized Electronic Medical Record (EMR), Internet of Medical Things (IOMT) wireless medical devices, and non-contact vital signs software as medical devices.

Two companies have also signed a distribution agreement where Docsun is appointed by UCrest as the exclusive distributor for the US market of the iMedic-Docsun integrated products. Docsun has committed contribute USD10 million or more revenue over a three year period. Docsun is a leading medical technology provider of non-contact, non-invasive, non-intrusive vital signs software as medical device.

Today, vital signs such as heart rate, blood pressure, blood oxygen, etc are measured using medical devices with sensor having direct contact with the body. Cholesterol and blood sugar are obtained from blood samples using invasive method.

With Docsun non-contact technologies, these vitals are obtained from the facial video image of a patient taken using the camera of the smart phone or the laptop. With its proprietary OCT technology that is color-agnostic, the powerful artificial intelligent system can extract several vital signs regardless of the color tone of the subject.

UCrest’s iMedic system is a digital hospital platform with telehealth and Clinical Management System (CMS) capabilities and over 30 FDA/CE approved wireless medical devices connecting to the mobile APP to the Cloud with the patented proprietary Internet of Medical Things (IOMT) technology and unique Artificial Intelligence processing capability, making “home is clinic”.

“iMedic-Docsun integrated product is a perfect platform for chronic disease management and simple acute diseases consultation and health monitoring, and we are extremely excited about rolling out the integrated products in the US market as it has the biggest potential,” remarked Ted Huang, President of Docsun.

“The Docsun non-contact technologies is based on very robust artificial technologies, and we will continue to further develop to include measurement of many other vital signs and biomarkers,” he added.

“We develop iMedic with the focus to empower the patients to manage their own health, shifting some of the personal health responsibility to the patients by having all kinds of medical devices at home connecting to the platform accessing their Electronic Medical Records (EMR) and online doctor consultation, turning home into a clinic.”, said Kah Yee Eg, CEO of UCrest.

“With the non-contact vitals technology, accessibility and convenience are improved significantly and cost will also be reduced substantially since most people have smartphone and/or laptop,” he commented.

Previous articleLangkawi Voted 4th Best Island To Visit In Asia
Next articleAirAsia Is Now Flying From Bali To Penang Twice-Weekly

LEAVE A REPLY

Please enter your comment!
Please enter your name here